Bigul

Novartis CEO Narasimhan sets up new leadership after four top exits

Narasimhan, who took over as CEO in February, is emphasising the role of digital technology in helping Novartis come up with winning new therapies
12-03-2018
Bigul

What to Watch: Novartis India gets 188-cr refund booster

Shares of Novartis India will remain in focus following receipt of an income tax refund. In a notice to the stock exchanges, the company has said that on accoun
01-03-2018
Bigul

Announcement under Regulation 30 (LODR)-Updates

Disclosure under SEBI (LODR) Regulations - Novartis India Limited ('Company') receives refund of INR 1879m on account of favourable order of the Income Tax Appellate Tribunal for FY 1994-95.
01-03-2018
Bigul

Novartis' take on what to expect as tech transforms healthcare

We will need to focus on true breakthroughs, therapies that are truly transformative - either life enhancing or meaningfully life changing.
26-02-2018
Bigul

Shareholding for the Period Ended February 06, 2018

Novartis India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended February 06, 2018. For more details, kindly Click here
06-02-2018
Bigul

Updates on Buyback Offer

Ambit Capital Pvt Ltd ("Manager to the Buyback Offer") has submitted to BSE a copy of Post Buyback Public Announcement for the attention of Equity Shareholders / Beneficial Owners of Equity Shares of Novartis India Ltd ("the Company").
31-01-2018
Bigul

Buy back

1. Extinguishment of equity shares as a result of the conclusion of buyback of 34,50,000 equity shares of face value of INR 5 each of Novartis India Limited (the 'Company'). 2. Reconciliation of share capital of the Company
30-01-2018
Bigul

Novartis India Q3 net profit soars 44 per cent at Rs 187.4 million

Novartis India also announced the appointment of Jawed Zia as vice chairman and managing director of the company effective March 1, 2018
29-01-2018
Bigul

Newspaper Publication

Newspaper advertisement of Post Buyback Public Announcement in respect of Buyback of equity shares of Novartis India Limited through the tender offer route Dear Sirs, Please find enclosed copies of Post Buyback Public Announcement, which has been published in the Financial Express, Jansatta and Navshakti on January 26, 2018, the contents of which are self-explanatory....
29-01-2018
Bigul

Appointment of Managing Director

Outcome of Board Meeting Dear Sirs, We refer to our letter dated December 29, 2017, informing you of our Board Meeting that was scheduled for today. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 2.45 p.m. The Board of Directors of the Company at this meeting approved the following:...
29-01-2018
Next Page
Close

Let's Open Free Demat Account